Monoclonal Anti-Mage-3 CTL Responses in Melanoma Patients Displaying Tumor Regression After Vaccination With a Recombinant Canarypox Virus
Journal of Immunology - United States
doi 10.4049/jimmunol.171.9.4898
Full Text
Open PDFAbstract
Available in full text
Date
October 20, 2003
Authors
Publisher
The American Association of Immunologists